Gene · 3451
IFNA17: interferon alpha 17
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. IFNA17: interferon alpha 17. Genes, record 3451. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3451
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P01571 | Interferon alpha-17 | 189 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents84
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4705273 A2 | 2026-03-11 | 540 | P01571 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 13736 | P01571 | Espacenet |
| JP 2025169942 A | 2025-11-14 | 1095 | P01571 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 6731 | P01571 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6650 | P01571 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6650 | P01571 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 13736 | P01571 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 6731 | P01571 | Espacenet |
| JP 2025013347 A | 2025-01-24 | 540 | P01571 | Espacenet |
| JP 2025502205 A | 2025-01-24 | 9812 | P01571 | Espacenet |
1 to 10 of 84
See all 84 patentsDrugs2
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
Trials10
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT01283139 | SIFALIMUMAB | PHASE2 | 2016-07-11 | ClinicalTrials.gov |
| NCT01031836 | SIFALIMUMAB | PHASE2 | 2018-11-19 | ClinicalTrials.gov |
| NCT00979654 | SIFALIMUMAB | PHASE2 | 2016-08-23 | ClinicalTrials.gov |
| NCT00962832 | RONTALIZUMAB | PHASE2 | ClinicalTrials.gov | |
| NCT00657189 | SIFALIMUMAB | PHASE2 | ClinicalTrials.gov | |
| NCT00541749 | RONTALIZUMAB | PHASE1 | ClinicalTrials.gov | |
| NCT00533091 | SIFALIMUMAB | PHASE1 | ClinicalTrials.gov | |
| NCT00482989 | SIFALIMUMAB | PHASE1 | ClinicalTrials.gov | |
| NCT00472758 | SIFALIMUMAB | PHASE1 | ClinicalTrials.gov | |
| NCT00299819 | SIFALIMUMAB | PHASE1 | ClinicalTrials.gov |
NIH grants1,175
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | IFNA17 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 14 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 12 | 2025 |
| UL1TR001866 | Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | 4 | 2025 |
| P30AI050409 | Center for AIDS Research at Emory University | 3 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 3 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 3 | 2025 |
| P30DK097512 | Indiana Diabetes Research Center | 3 | 2025 |
| P51OD011132 | Emory National Primate Research Center | 3 | 2025 |
| R01AI163029 | Inborn errors of immunity in patients with life-threatening COVID-19 | 3 | 2025 |
| P01CA108671 | Myeloproliferative Neoplasms-Research Consortium | 2 | 2025 |
1 to 10 of 1,175Source NIH's project files
See all 1,175 nih grantsPapers2,506
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predicting chronic immune thrombocytopenia in children using IFNA17 rs9298814 polymorphism and clinical features: a study from a low- and middle-income country. | Thromb Res | 2026 | 42600549 | PubTator, text mining | PubMed |
| Plastome convergence across endoparasitic plant lineages: genome reduction, high AT bias, elevated substitution rates, and functional persistence in Mitrastemon yamamotoi. | Ann Bot | 2026 | 42548282 | PubTator, text mining | PubMed |
| Reduction of virus isolation effectiveness from throat swab double positive to H1N1pdm09 and H3N2 influenza A virus strain with SARS-CoV-2 virus in cell cultures. | Mol Biol Rep | 2026 | 41931213 | PubTator, text mining | PubMed |
| Construction of a risk prediction model for severe community-acquired pneumonia in children in Qinghai region. | BMJ Paediatr Open | 2026 | 41922063 | PubTator, text mining | PubMed |
| Sex-Specific Salivary Biochemical Composition in a Healthy Population. | Int J Mol Sci | 2026 | 41828440 | PubTator, text mining | PubMed |
| Essential role of hsa-miR-203a-3p in type I interferons immune homeostasis during influenza and NDV infection. | RNA Biol | 2026 | 41784292 | PubTator, text mining | PubMed |
| Unmasking Viral Causes of Hospitalized Respiratory Infection: Five Years of Respiratory Virus Surveillance in Vietnam by Multiplex Real-Time PCR Assay. | Viruses | 2026 | 41754495 | PubTator, text mining | PubMed |
| Changes in Serum Levels of NINJ1 and HMGB1 in Children with Kawasaki Disease and Their Clinical Significance. | Biomedicines | 2026 | 41751301 | PubTator, text mining | PubMed |
| ISG15 orchestrates dynamic crosstalk between mitochondrial fat oxidation and type 1 interferon in myeloid cells. | bioRxiv | 2026 | 41743980 | PubTator, text mining | PubMed |
| Low-dose VSV-EBOV vaccination provides rapid protection from lethal Ebola virus challenge. | bioRxiv | 2026 | 41727071 | PubTator, text mining | PubMed |
1 to 10 of 2,506
See all 2,506 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3451
GET https://conductscience.org/api/genes/v1/3451/patents?page=2